BAX

Product Revenue Segments

Latest: 2025 (2025-12-31) · Total: $10.86B
SegmentRevenueShare
Medical Products And Therapies
$5.30B48.8%
Healthcare Systems and Technologies
$3.07B28.3%
Pharmaceuticals
$2.49B22.9%
Other
$00.0%

Geographic Revenue Segments

Latest: 2025 (2025-12-31) · Total: $11.24B
SegmentRevenueShare
UNITED STATES
$6.12B54.4%
Western Europe, Canada, Japan, Australia and New Zealand
$3.73B33.2%
EMEA
$1.39B12.4%
Other
$00.0%
Source: SEC filings via FMP · Last updated May 25, 2026
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.